Bank of New York Mellon’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.69M | Sell |
232,343
-10,883
| -4% | -$220K | ﹤0.01% | 2475 |
|
|
2026
Q1 | $4.76M | Sell |
243,226
-15,835
| -6% | -$387K | ﹤0.01% | 2340 |
|
|
2025
Q4 | $6.94M | Sell |
259,061
-8,767
| -3% | -$226K | ﹤0.01% | 2130 |
|
|
2025
Q3 | $7.14M | Sell |
267,828
-46,975
| -15% | -$1.21M | ﹤0.01% | 2121 |
|
|
2025
Q2 | $7.23M | Buy |
314,803
+48,728
| +18% | +$1.21M | ﹤0.01% | 2063 |
|
|
2025
Q1 | $7.71M | Sell |
266,075
-19,788
| -7% | -$632K | ﹤0.01% | 1995 |
|
|
2024
Q4 | $10.6M | Buy |
285,863
+32,112
| +13% | +$1.47M | ﹤0.01% | 1895 |
|
|
2024
Q3 | $12.3M | Sell |
253,751
-36,203
| -12% | -$1.59M | ﹤0.01% | 1821 |
|
|
2024
Q2 | $11.6M | Sell |
289,954
-4,529
| -2% | -$188K | ﹤0.01% | 1882 |
|
|
2024
Q1 | $12.9M | Sell |
294,483
-18,855
| -6% | -$974K | ﹤0.01% | 1830 |
|
|
2023
Q4 | $19.4M | Sell |
313,338
-13,169
| -4% | -$692K | ﹤0.01% | 1613 |
|
|
2023
Q3 | $15M | Sell |
326,507
-15,614
| -5% | -$852K | ﹤0.01% | 1700 |
|
|
2023
Q2 | $19.7M | Sell |
342,121
-5,091
| -1% | -$226K | ﹤0.01% | 1564 |
|
|
2023
Q1 | $13M | Buy |
347,212
+1,196
| +0.3% | +$39.2K | ﹤0.01% | 1788 |
|
|
2022
Q4 | $9.7M | Sell |
346,016
-16,859
| -5% | -$490K | ﹤0.01% | 1958 |
|
|
2022
Q3 | $10.2M | Sell |
362,875
-2,971
| -0.8% | -$97K | ﹤0.01% | 1890 |
|
|
2022
Q2 | $12.7M | Sell |
365,846
-35,559
| -9% | -$1.27M | ﹤0.01% | 1798 |
|
|
2022
Q1 | $14.4M | Buy |
401,405
+30,462
| +8% | +$864K | ﹤0.01% | 1870 |
|
|
2021
Q4 | $8.64M | Buy |
370,943
+6,943
| +2% | +$142K | ﹤0.01% | 2180 |
|
|
2021
Q3 | $6.92M | Buy |
364,000
+8,452
| +2% | +$166K | ﹤0.01% | 2330 |
|
|
2021
Q2 | $7.17M | Sell |
355,548
-23,135
| -6% | -$436K | ﹤0.01% | 2312 |
|
|
2021
Q1 | $6.94M | Sell |
378,683
-7,669
| -2% | -$143K | ﹤0.01% | 2285 |
|
|
2020
Q4 | $7.77M | Buy |
386,352
+327
| +0.1% | +$6.36K | ﹤0.01% | 2135 |
|
|
2020
Q3 | $7.24M | Buy |
386,025
+8,421
| +2% | +$170K | ﹤0.01% | 2031 |
|
|
2020
Q2 | $8.48M | Buy |
377,604
+4,624
| +1% | +$84.7K | ﹤0.01% | 1932 |
|
|
2020
Q1 | $5.54M | Sell |
372,980
-15,785
| -4% | -$275K | ﹤0.01% | 2029 |
|
|
2019
Q4 | $7.5M | Buy |
388,765
+5,444
| +1% | +$104K | ﹤0.01% | 2137 |
|
|
2019
Q3 | $7.6M | Sell |
383,321
-6,577
| -2% | -$137K | ﹤0.01% | 2078 |
|
|
2019
Q2 | $8.23M | Sell |
389,898
-10,482
| -3% | -$219K | ﹤0.01% | 2073 |
|
|
2019
Q1 | $8.18M | Sell |
400,380
-46,748
| -10% | -$1.05M | ﹤0.01% | 2079 |
|
|
2018
Q4 | $8.9M | Buy |
447,128
+28,225
| +7% | +$556K | ﹤0.01% | 1972 |
|
|
2018
Q3 | $8.06M | Buy |
418,903
+10,837
| +3% | +$193K | ﹤0.01% | 2151 |
|
|
2018
Q2 | $6.23M | Sell |
408,066
-6,322
| -2% | -$110K | ﹤0.01% | 2277 |
|
|
2018
Q1 | $7.77M | Buy |
414,388
+9,599
| +2% | +$180K | ﹤0.01% | 2117 |
|
|
2017
Q4 | $7.79M | Sell |
404,789
-51,367
| -11% | -$959K | ﹤0.01% | 2112 |
|
|
2017
Q3 | $8.15M | Sell |
456,156
-22,490
| -5% | -$370K | ﹤0.01% | 2087 |
|
|
2017
Q2 | $8.55M | Sell |
478,646
-41,156
| -8% | -$653K | ﹤0.01% | 2064 |
|
|
2017
Q1 | $7.54M | Buy |
519,802
+53,214
| +11% | +$837K | ﹤0.01% | 2110 |
|
|
2016
Q4 | $8.6M | Buy |
466,588
+31,864
| +7% | +$620K | ﹤0.01% | 2032 |
|
|
2016
Q3 | $8.25M | Buy |
434,724
+243,875
| +128% | +$4.43M | ﹤0.01% | 1970 |
|
|
2016
Q2 | $3.08M | Buy |
190,849
+62,731
| +49% | +$885K | ﹤0.01% | 2478 |
|
|
2016
Q1 | $1.54M | Buy |
128,118
+3,176
| +3% | +$37.4K | ﹤0.01% | 2818 |
|
|
2015
Q4 | $1.78M | Hold |
124,942
| – | – | ﹤0.01% | 2788 |
|
|
2015
Q3 | $1.46M | Buy |
124,942
+2,429
| +2% | +$36.4K | ﹤0.01% | 2933 |
|
|
2015
Q2 | $2.15M | Buy |
122,513
+87,722
| +252% | +$1.37M | ﹤0.01% | 2866 |
|
|
2015
Q1 | $521K | Buy |
34,791
+7,574
| +28% | +$101K | ﹤0.01% | 3587 |
|
|
2014
Q4 | $316K | Buy |
27,217
+6,175
| +29% | +$67.3K | ﹤0.01% | 3766 |
|
|
2014
Q3 | $246K | Buy |
+21,042
| New | +$219K | ﹤0.01% | 3837 |
|
Other funds holding AMPH
LG
ETC
Bank of New York Mellon's AMPH Position: Q2 2026 in Review
Bank of New York Mellon reduced its Amphastar Pharmaceuticals (AMPH) stake by 4.5% in Q2 2026, selling an estimated $220K and leaving 232,343 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2475.
Bank of New York Mellon first reported a position in AMPH in Q3 2014 and has held it in 48 quarters since. The position peaked at $19.7M in Q2 2023. 70 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Bank of New York Mellon held 232,343 shares of Amphastar Pharmaceuticals worth $4.69M as of Q2 2026.
- Bank of New York Mellon sold 10,883 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $220K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2475 holding.
- Bank of New York Mellon first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 48 quarters since.
- Bank of New York Mellon's Amphastar Pharmaceuticals position peaked at $19.7M in Q2 2023.
- 70 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.